CANDEL THERAPEUTICS I
5.0309
08-November-24 09:32:31
15 minutes delayed
Stocks
-0.0591
-1.16%
Today's range
5.0300 - 5.1500
ISIN
N/A
Source
NASDAQ
-
02 Mar 2022 08:00:02 By Nasdaq GlobeNewswire
-
01 Mar 2022 08:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Appoints Dr. Francesca Barone as Chief Scientific Officer
03 Feb 2022 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at Two Upcoming Investor Conferences
05 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
15 Dec 2021 05:00:00 By Nasdaq GlobeNewswire
-
10 Dec 2021 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights
12 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
12 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in Three Upcoming Investor Conferences
02 Nov 2021 08:00:03 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Data Presentations on its Oncolytic Viral Immunotherapies
01 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
19 Oct 2021 08:00:02 By Nasdaq GlobeNewswire
-
04 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
-
01 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
-
09 Sep 2021 08:00:03 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights
08 Sep 2021 08:00:03 By Nasdaq GlobeNewswire
-
17 Aug 2021 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Pricing of Initial Public Offering
26 Jul 2021 21:05:38 By Nasdaq GlobeNewswire